SUMITOMO CHEMICAL INDIA LIMITED Financials Sumitomo Chemical India Limited Bombay S.E.
Equities
SUMICHEM
INE258G01013
Agricultural Chemicals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 478.2 INR | -0.30% |
|
-2.78% | +18.31% |
| 28/05 | Transcript : Sumitomo Chemical India Limited, Q4 2024 Earnings Call, May 28, 2024 | |
| 28/05 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
Valuation
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 92,192 | 1,45,102 | 2,23,867 | 2,12,686 | 2,38,966 | - | - |
| Enterprise Value (EV) 1 | 91,039 | 1,39,991 | 2,19,891 | 2,12,686 | 1,73,578 | 2,38,966 | 2,38,966 |
| P/E ratio | 45 x | 42 x | 52.8 x | 42.4 x | 47 x | 46.6 x | 38.7 x |
| Yield | 0.3% | 0.28% | 0.22% | 0.28% | 0.21% | 0.26% | 0.3% |
| Capitalization / Revenue | 3.8 x | 5.49 x | 7.3 x | 6.06 x | 6.1 x | 7.22 x | 6.15 x |
| EV / Revenue | 3.8 x | 5.49 x | 7.3 x | 6.06 x | 6.1 x | 7.22 x | 6.15 x |
| EV / EBITDA | 27.7 x | 29.8 x | 37.3 x | 31.9 x | 36.7 x | 37.9 x | 31 x |
| EV / FCF | 50.3 x | 38 x | 207 x | 78.9 x | 48.7 x | 67.8 x | 52.3 x |
| FCF Yield | 1.99% | 2.63% | 0.48% | 1.27% | 2.05% | 1.47% | 1.91% |
| Price to Book | 7.55 x | 9.41 x | 11.6 x | 8.93 x | 8.96 x | 8.34 x | 6.92 x |
| Nbr of stocks (in thousands) | 4,99,146 | 4,99,146 | 4,99,146 | 4,99,146 | 4,99,146 | - | - |
| Reference price 2 | 184.7 | 290.7 | 448.5 | 426.1 | 478.8 | 478.8 | 478.8 |
| Announcement Date | 05/06/20 | 28/05/21 | 27/05/22 | 18/05/23 | 27/05/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 24,247 | 26,449 | 30,646 | 35,110 | 28,439 | 33,084 | 38,866 |
| EBITDA 1 | 3,332 | 4,869 | 5,999 | 6,666 | 4,735 | 6,306 | 7,701 |
| EBIT 1 | 2,922 | 4,403 | 5,551 | 6,147 | 4,120 | 5,504 | 6,820 |
| Operating Margin | 12.05% | 16.65% | 18.11% | 17.51% | 14.49% | 16.64% | 17.55% |
| Earnings before Tax (EBT) 1 | 2,665 | 4,533 | 5,757 | 6,542 | 5,033 | 6,732 | 8,119 |
| Net income 1 | 2,047 | 3,454 | 4,236 | 5,022 | 3,697 | 5,121 | 6,205 |
| Net margin | 8.44% | 13.06% | 13.82% | 14.3% | 13% | 15.48% | 15.96% |
| EPS 2 | 4.100 | 6.920 | 8.490 | 10.06 | 7.400 | 10.27 | 12.38 |
| Free Cash Flow 1 | 1,834 | 3,822 | 1,083 | 2,695 | 4,910 | 3,524 | 4,568 |
| FCF margin | 7.56% | 14.45% | 3.53% | 7.68% | 17.28% | 10.65% | 11.75% |
| FCF Conversion (EBITDA) | 55.04% | 78.49% | 18.05% | 40.43% | 116.97% | 55.89% | 59.31% |
| FCF Conversion (Net income) | 89.6% | 110.64% | 25.56% | 53.66% | 145.54% | 68.81% | 73.61% |
| Dividend per Share 2 | 0.5500 | 0.8000 | 1.000 | 1.200 | 1.000 | 1.250 | 1.440 |
| Announcement Date | 05/06/20 | 28/05/21 | 27/05/22 | 18/05/23 | 27/05/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 5,609 | 5,343 | 7,820 | 9,104 | 7,072 | 6,651 | 9,855 | 11,217 | 7,537 | 6,516 | 7,242 | 10,687 | 6,025 | 6,479 |
| EBITDA 1 | 780.2 | 713.3 | 1,498 | 2,147 | 1,265 | 1,089 | 1,876 | 2,780 | 1,204 | 805.7 | 806.3 | 2,302 | 947 | 948.8 |
| EBIT | - | - | - | - | - | - | - | - | - | - | - | - | 574 | 708.9 |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | 9.53% | 10.94% |
| Earnings before Tax (EBT) 1 | 709.2 | - | 1,423 | - | - | 1,041 | 1,797 | 2,720 | 1,209 | 816.2 | 833 | 2,422 | 921 | 977 |
| Net income 1 | 541.5 | 541 | 1,057 | - | - | 746.6 | 1,381 | 2,015 | 904.8 | 721.3 | 616.8 | 1,815 | 659 | 760.6 |
| Net margin | 9.65% | 10.13% | 13.52% | - | - | 11.23% | 14.02% | 17.96% | 12.01% | 11.07% | 8.52% | 16.98% | 10.94% | 11.74% |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | 1.100 | 1.500 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 05/02/21 | 28/05/21 | 04/08/21 | 29/10/21 | 03/02/22 | 27/05/22 | 09/08/22 | 28/10/22 | 03/02/23 | 18/05/23 | 31/07/23 | - | - | - |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | 1,153 | 5,110 | 3,976 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 1,834 | 3,822 | 1,083 | 2,695 | 4,910 | 3,524 | 4,568 |
| ROE (net income / shareholders' equity) | 18% | 25% | 24.4% | 23.3% | 13.2% | 18.3% | 18.7% |
| ROA (Net income/ Total Assets) | 10.3% | 14.5% | 14.9% | - | - | - | - |
| Assets 1 | 19,831 | 23,881 | 28,408 | - | - | - | - |
| Book Value Per Share 2 | 24.50 | 30.90 | 38.60 | 47.70 | 53.40 | 57.40 | 69.20 |
| Cash Flow per Share | - | 8.520 | - | - | - | - | - |
| Capex 1 | 380 | 433 | 1,135 | 1,199 | 1,800 | 1,700 | 1,900 |
| Capex / Sales | 1.57% | 1.64% | 3.7% | 3.41% | 6.33% | 5.14% | 4.89% |
| Announcement Date | 05/06/20 | 28/05/21 | 27/05/22 | 18/05/23 | 27/05/24 | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
478.8
INR
Average target price
483.6
INR
Spread / Average Target
+1.01%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +10.75% | 3.76TCr | |
| -.--% | 1.19TCr | |
| +26.80% | 765.95Cr | |
| -10.21% | 718.33Cr | |
| +8.67% | 690.97Cr | |
| -13.42% | 552.28Cr | |
| -13.76% | 514.54Cr | |
| -2.40% | 513.79Cr | |
| +30.96% | 490.2Cr |
- Stock Market
- Equities
- SUMICHEM Stock
- SUMICHEM Stock
- Financials Sumitomo Chemical India Limited
